向着有针对性的痴呆症预防:德国的人口可归因部分和风险概况
Iris Blotenberg1,2, Jochen René Thyrian1,3
1German Center for Neurodegenerative Diseases (DZNE) Greifswald Germany.
Alzheimer's & dementia (Amsterdam, Netherlands)
|December 1, 2025
概括
在德国,有效预防痴呆症是可能的,36%的病例与可修改的风险因素有关. 针对这些因素可以在2050年之前预防数十万例痴呆病例.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 有效的痴呆症预防策略需要了解可修改的风险因素分布.
- 识别高风险子组对于有针对性的干预至关重要.
研究的目的:
- 为了估计德国的痴呆症预防潜力.
- 为精确的公共卫生方法确定不同的风险概况.
主要方法:
- 来自2023年德国老龄化调查 (n=4992) 的全国代表性数据的分析.
- 为可修改的风险因素计算人口归因分数和潜在影响分数.
- 使用隐性类别分析来识别风险概况.
主要成果:
- 据估计,德国36%的痴呆病例是由于可修改的风险因素造成的.
- 降低15%至30%的风险因子患病率,可以在2050年之前预防17万至33万例.
- 确定了四个不同的风险概况 (代谢,感觉障碍,酒精,较低风险),与人口和地区特征相关.
结论:
- 通过可修改的风险因素降低,在预防痴呆症方面存在重大的国家潜力.
- 识别出具有共同风险模式的人口子组可以为有针对性,公平和高效的预防策略提供信息.
相关概念视频
Dementia
487
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
487
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Prevalence and Incidence
1.5K
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.5K
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212


